Novo Nordisk to Present Liver Data on Wegovy and Efruxifermin

Novo Nordisk says it will present new liver data on Wegovy 2.4 mg and investigational efruxifermin at The Liver Meeting 2026. The PLATINUM-Truveta analysis compared semaglutide 2.4 mg effectiveness.